EAEU Development and Production of Radiopharmaceuticals: Major Achievements, Growth Vectors, and Prospects

Abstract

A seven-year development plan of Russian pharmaceutical industry (Pharma 2030) includes all the tools that would allow Russia to implement technological self-sufficiency in pharmaceutical industry, in particular in development, research, and production of radiopharmaceuticals. Dmitry A. Rozhdestvensky, Cand. Sci. (Med.), Coordination manager for circulation of medicinal products and medical devices, Technical Regulation and Accreditation Department of the Eurasian Economic Commission, shares his insights on how to develop, produce, authorise, and apply radionuclide therapy in the Member States of the Eurasian Economic Union (EAEU).